Paula Montero Llopis

Paula Montero Llopis

Auto-generated profile, based on publicly available information

Paula Montero Llopis

Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2022 in Nature
Verified
Journal Article
Closed access
PDF file
RLRebecca C. Larson
Rebecca C. Larson
MKMichael C. Kann
Michael C. Kann
SBStefanie R. Bailey
Stefanie R. Bailey
NHNicholas J. Haradhvala
Nicholas J. Haradhvala
PLPaula Montero Llopis
Paula Montero Llopis
MMMarcela V. Maus
Marcela V. Maus

20 April 2022 in Cell
Verified
Journal Article
Closed access
PBPilar Baldominos
Pilar Baldominos
ABAlex Barbera-Mourelle
Alex Barbera-Mourelle
OBOlga Barreiro
Olga Barreiro
YHYu Huang
Yu Huang
AWAndrew Wight
Andrew Wight
JAJudith Agudo
Judith Agudo

20 December 2021 in Nature
Verified
Journal Article
Closed access
PDF file
LCLars E. Clark
Lars E. Clark
SCSarah A. Clark
Sarah A. Clark
CLChieYu Lin
ChieYu Lin
JLJianying Liu
Jianying Liu
ACAdrian Coscia
Adrian Coscia
JAJonathan Abraham
Jonathan Abraham

23 February 2024 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
MWMarc Wehrli
Marc Wehrli
SGSamantha Guinn
Samantha Guinn
FBFilippo Birocchi
Filippo Birocchi
AKAdam Kuo
Adam Kuo
YSYi Sun
Yi Sun
MMMarcela V. Maus
Marcela V. Maus
Purpose: Targeting solid tumors with chimeric antigen receptor (CAR) T cells remains challenging due to heterogenous target antigen expression, antigen escape, and the immunosuppressive tumor microenvironment (TME). Pancreatic cancer is characterized by a thick stroma generated by cancer-associated fibroblasts (CAF), which may contribute to the limited efficacy of mesothelin-directed CAR T cells in early-phase clinical trials. To provide a more favorable TME for CAR T cells to target pancreatic ductal adenocarcinoma (PDAC), we generated T cells with an antimesothelin CAR and a secreted T-cell–engaging molecule (TEAM) that targets CAF through fibroblast activation protein (FAP) and engages T cells through CD3 (termed mesoFAP CAR-TEAM cells). Experimental Design: Using a suite of in vitro, in vivo, and ex vivo patient-derived models containing cancer cells and CAF, we examined the ability of mesoFAP CAR-TEAM cells to target PDAC cells and CAF within the TME. We developed and used patient-derived ex vivo models, including patient-derived organoids with patient-matched CAF and patient-derived organotypic tumor spheroids. Results: We demonstrated specific and significant binding of the TEAM to its respective antigens (CD3 and FAP) when released from mesothelin-targeting CAR T cells, leading to T-cell activation and cytotoxicity of the target cell. MesoFAP CAR-TEAM cells were superior in eliminating PDAC and CAF compared with T cells engineered to target either antigen alone in our ex vivo patient-derived models and in mouse models of PDAC with primary or metastatic liver tumors. Conclusions: CAR-TEAM cells enable modification of tumor stroma, leading to increased elimination of PDAC tumors. This approach represents a promising treatment option for pancreatic cancer.

7 June 2021 in Nature Methods
Verified
Journal Article
Closed access
PDF file
PLPaula Montero Llopis
Paula Montero Llopis
RSRebecca A. Senft
Rebecca A. Senft
TRTim J. Ross-Elliott
Tim J. Ross-Elliott
RSRyan Stephansky
Ryan Stephansky
DKDaniel P. Keeley
Daniel P. Keeley
MIMichelle Itano
Michelle Itano

14 September 2023 in Nature Methods
Verified
Journal Article
Open access
PDF file
CSChristopher Schmied
Christopher Schmied
MNMichael S. Nelson
Michael S. Nelson
SASergiy Avilov
Sergiy Avilov
GBGert-Jan Bakker
Gert-Jan Bakker
CBCristina Bertocchi
Cristina Bertocchi
HJHelena Klara Jambor
Helena Klara Jambor
Images document scientific discoveries and are prevalent in modern biomedical research. Microscopy imaging in particular is currently undergoing rapid technological advancements. However, for scientists wishing to publish obtained images and image-analysis results, there are currently no unified guidelines for best practices. Consequently, microscopy images and image data in publications may be unclear or difficult to interpret. Here, we present community-developed checklists for preparing light microscopy images and describing image analyses for publications. These checklists offer authors, readers and publishers key recommendations for image formatting and annotation, color selection, data availability and reporting image-analysis workflows. The goal of our guidelines is to increase the clarity and reproducibility of image figures and thereby to heighten the quality and explanatory power of microscopy data.